Description
Artesunate Tablets
• Product Overview
Artesunate Tablets are antimalarial medicines belonging to the artemisinin derivative class. They are used for the treatment of acute uncomplicated malaria, particularly infections caused by Plasmodium falciparum, including chloroquine-resistant strains. Artesunate acts rapidly to reduce the malaria parasite load and is generally used as part of Artemisinin-based Combination Therapy (ACT) to improve treatment effectiveness and reduce the risk of resistance.
• Available Strengths
– Artesunate 50 mg Tablets
– Artesunate 100 mg Tablets
– Artesunate 200 mg Tablets
• Therapeutic Category
Antimalarial Agent (Artemisinin Derivative)
• Indications
Artesunate Tablets are indicated for the treatment of:
– Acute Uncomplicated Plasmodium falciparum Malaria
– Chloroquine-Resistant Malaria
– Mixed Plasmodium Infections (as recommended by treatment guidelines)
– Completion of oral therapy following initial treatment of severe malaria (as prescribed)
– Malaria treatment as part of Artemisinin-based Combination Therapy (ACT)
• Common Side Effects
Some patients may experience:
– Headache
– Dizziness
– Nausea
– Vomiting
– Abdominal pain
– Loss of appetite
– Weakness
• Serious Side Effects
Seek immediate medical attention if any of the following occur:
– Severe allergic reactions (Anaphylaxis)
– Severe skin reactions
– Hemolytic anemia (rare)
– Irregular heartbeat (rare)
– Difficulty breathing
– Persistent vomiting or severe weakness
• Precautions
– Use only under the supervision of a qualified healthcare professional.
– Artesunate should generally be used in combination with another effective antimalarial medicine.
– Complete the full prescribed treatment course.
– Inform your healthcare provider about all medicines being taken.
– Use cautiously in patients with severe liver or kidney impairment.
– Store below 30°C in a cool, dry place away from moisture and direct sunlight.
• Technical Information
• Active Ingredient
Artesunate
• Mechanism of Action
Artesunate is rapidly converted to its active metabolite, dihydroartemisinin (DHA). It produces reactive free radicals within malaria parasites, damaging essential parasite proteins and leading to rapid parasite death.
• Dosage Form
Tablet
• Route of Administration
Oral
• Shelf Life
24–36 Months (depending on packaging and regulatory requirements)
• Storage Conditions
Store below 30°C in a dry place protected from moisture and direct sunlight.
• Product Specifications
Product Name:- Artesunate Tablets
Generic Name:- Artesunate
Strengths:- 50 mg, 100 mg, 200 mg
Dosage Form:- Tablet
Category:- Antimalarial
Packaging:- Blister / Alu-Alu / Customized Export Packing
Shelf Life:- 24–36 Months
Storage:- Below 30°C
Origin:- India
• Regulatory Status & Supply Information
– Manufactured in WHO-GMP compliant facilities.
– Available for international export markets.
– Export documentation support available.
– Private Label Manufacturing available.
– Third-Party Manufacturing available.
– Customized export packaging available.
– Bulk quantities available for distributors, wholesalers, hospitals, NGOs, pharmacies, and government tenders.
• Who Should Source This Product?
This product is ideal for:
– Pharmaceutical Importers
– Pharmaceutical Distributors
– Government Procurement Agencies
– Hospital Procurement Companies
– NGOs & Global Health Organizations
– International Tender Suppliers
– Pharmacy Chains
– Private Label Brands
• Why Source From Mediora Exports?
– Trusted Pharmaceutical Exporter from India
– WHO-GMP Manufacturing Partners
– Competitive International Pricing
– Wide Product Portfolio
– Reliable Global Supply Chain
– Flexible Packaging Options
– Timely Delivery
– Complete Export Documentation Support
– Dedicated Export Support Team
• Contact Details
Mediora Exports
📧 Email: info@medioraexports.com
📱 Phone/WhatsApp: +91 99047 64844
For product inquiries, quotations, distributorship opportunities, private labeling, and bulk export orders, please contact our team.

Reviews
There are no reviews yet.